RAS activation inhibits TGF-β-induced KLF5 acetylation [67], and the deacetylation state of KLF5 may be an important mechanism, by which KLF5 and HDAC promote cell proliferation and tumor growth [68]. The gene discussed is KLF5; the disease is neoplasm.